Biomarker Enterprise to Attack DKD

Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) but there are no effective means to prevent or cure DKD. BEAt-DKD comprises a network of basic and clinical research experts, including the leaders of the diabetes and kidney disease-relevant consortia and leading pharmaceutical companies to enable a holistic system medicine view of the pathogenesis to identify of target mechanism and pathways underlying initiation and progression of DKD. The identification and validation of biomarkers of disease progression and treatment responses representing first steps towards precision medicine in the disease management.


Martinistraße 52
Campus Research N27
20246 Hamburg Germany
This email address is being protected from spambots. You need JavaScript enabled to view it.

University Medical Center Hamburg - Eppendorf